The role of eradication of Helicobacter pylori infection in the prevention of gastric cancer (based on the Maastricht-VI consensus report)
https://doi.org/10.30629/0023-2149-2023-101-4-5-229-234
Abstract
The article discusses the statements of the section of the consensus meeting “Maastricht-VI” (2021), dedicated to the role of H.pylori infection eradication in prevention of the development of gastric cancer. Experts have confi rmed that this infection is currently the main etiological factor of gastric cancer. Its eradication leads to regression of atrophic changes in the gastric mucosa and reduces the risk of development of gastric cancer. This makes it necessary to implement the population program “test and treat” for the purpose of cancer prevention and to include it among the priorities of healthcare.
About the Authors
A. A. SheptulinRussian Federation
Sheptulin Arkady A.
119991, Moscow
Yu. S. Rabotyagova
Russian Federation
Rabotyagova Yulia S.
295051, Simferopol
References
1. Malfertheiner P., Megraud F., O’Morain C.A., Gisbert J.P., Kuipers E.J., Axon A.T. et al. Management of Helicobacter pylori infection — the Maastricht V/Florence consensus report. Gut. 2017;66(1):6–30. DOI: 10.1136/gutjnl-2016-312288
2. Malfertheiner P., Megraud F., Rokkas T., Gisbert J.P., Liou I.-M., Schulz C. et al. Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report. Gut. 2022;0:1–39. Epub ahead. DOI: 10.1136/gutjnl-2022- 3277451
Review
For citations:
Sheptulin A.A., Rabotyagova Yu.S. The role of eradication of Helicobacter pylori infection in the prevention of gastric cancer (based on the Maastricht-VI consensus report). Clinical Medicine (Russian Journal). 2023;101(4-5):229–234. (In Russ.) https://doi.org/10.30629/0023-2149-2023-101-4-5-229-234